Responses
Diabetes and endocrinology
Protocol
Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.